Cargando…

Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas

The growing interest in neuroendocrine tumours is due to the dynamic growth of detection of this type of cancer. Neuroendocrine tumours (neuroendocrine neoplasms – NENs / neuroendocrine tumours – NETs) derive from glands, groups of endocrine cells and diffuse neuroendocrine system cells. Mainly they...

Descripción completa

Detalles Bibliográficos
Autores principales: Gut, Paweł, Fischbach, Jakub, Kamiński, Grzegorz, Ruchała, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687448/
https://www.ncbi.nlm.nih.gov/pubmed/23788913
http://dx.doi.org/10.5114/wo.2012.31764
_version_ 1782273930054074368
author Gut, Paweł
Fischbach, Jakub
Kamiński, Grzegorz
Ruchała, Marek
author_facet Gut, Paweł
Fischbach, Jakub
Kamiński, Grzegorz
Ruchała, Marek
author_sort Gut, Paweł
collection PubMed
description The growing interest in neuroendocrine tumours is due to the dynamic growth of detection of this type of cancer. Neuroendocrine tumours (neuroendocrine neoplasms – NENs / neuroendocrine tumours – NETs) derive from glands, groups of endocrine cells and diffuse neuroendocrine system cells. Mainly they derive from the gastrointestinal tract (gastroenteropancreatic-neuroendocrine tumours – GEP-NETs). Currently the modified WHO classification from 2010 is widely used. An important element in the choice of treatment is histological maturity based on mitotic activity and on assessment of proliferation activity (Ki-67). The treatment of choice is surgery. In most cases, complete surgical removal is impossible because of the advanced staging at the time of diagnosis. In well-differentiated neoplasms where the expression of somatostatin receptors is expected, patients are qualified for somatostatin analogues therapy. Poorly differentiated lesions are qualified for chemotherapy. In the guidelines of ENETS (European Neuroendocrine Tumor Society) from 2007 the rules concerning monitoring depending on the WHO classification were specified.
format Online
Article
Text
id pubmed-3687448
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-36874482013-06-20 Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas Gut, Paweł Fischbach, Jakub Kamiński, Grzegorz Ruchała, Marek Contemp Oncol (Pozn) Review The growing interest in neuroendocrine tumours is due to the dynamic growth of detection of this type of cancer. Neuroendocrine tumours (neuroendocrine neoplasms – NENs / neuroendocrine tumours – NETs) derive from glands, groups of endocrine cells and diffuse neuroendocrine system cells. Mainly they derive from the gastrointestinal tract (gastroenteropancreatic-neuroendocrine tumours – GEP-NETs). Currently the modified WHO classification from 2010 is widely used. An important element in the choice of treatment is histological maturity based on mitotic activity and on assessment of proliferation activity (Ki-67). The treatment of choice is surgery. In most cases, complete surgical removal is impossible because of the advanced staging at the time of diagnosis. In well-differentiated neoplasms where the expression of somatostatin receptors is expected, patients are qualified for somatostatin analogues therapy. Poorly differentiated lesions are qualified for chemotherapy. In the guidelines of ENETS (European Neuroendocrine Tumor Society) from 2007 the rules concerning monitoring depending on the WHO classification were specified. Termedia Publishing House 2012-11-20 2012 /pmc/articles/PMC3687448/ /pubmed/23788913 http://dx.doi.org/10.5114/wo.2012.31764 Text en Copyright © 2012 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Gut, Paweł
Fischbach, Jakub
Kamiński, Grzegorz
Ruchała, Marek
Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
title Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
title_full Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
title_fullStr Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
title_full_unstemmed Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
title_short Contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
title_sort contemporary methods of therapy and follow-up of neuroendocrine tumours of the gastrointestinal tract and the pancreas
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687448/
https://www.ncbi.nlm.nih.gov/pubmed/23788913
http://dx.doi.org/10.5114/wo.2012.31764
work_keys_str_mv AT gutpaweł contemporarymethodsoftherapyandfollowupofneuroendocrinetumoursofthegastrointestinaltractandthepancreas
AT fischbachjakub contemporarymethodsoftherapyandfollowupofneuroendocrinetumoursofthegastrointestinaltractandthepancreas
AT kaminskigrzegorz contemporarymethodsoftherapyandfollowupofneuroendocrinetumoursofthegastrointestinaltractandthepancreas
AT ruchałamarek contemporarymethodsoftherapyandfollowupofneuroendocrinetumoursofthegastrointestinaltractandthepancreas